SW1990 tumor-bearing mice were given one infusion of human T cells and treated with 10ug EGFR, HER2, and EGFRxHER2 T-BsAbs every 3–4 days until tumors were harvested 10 days after the start of treatment (Fig. 4A). This evidence concerns the gene EGFR and neoplasm.